top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
Autore Allison Simon J
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (206 p.)
Soggetto topico History of engineering & technology
Technology: general issues
Soggetto non controllato 5-FU resistance
8-hydroxydaidzein
affibody drug conjugate (AffiDC)
affibody molecule
albumin binding domain
angiogenesis
anti-cancer agent
anticancer drug
apoptosis
AQ4N
autophagy
B-lactam steroid alkylators
BCR-ABL
biomarker
bioprecursor
breast cancer
BxPC-3
c-myc
cancer hallmarks
CCN1
colorectal cancer
Connectivity Map
CYP1A1
CYP1B1
CYP2W1
Cytochrome P450
DM1
drug repurposing
duocarmycin
EGFR tyrosine kinase inhibitor
emtansine
expression
gene silencing
Genomics of Drug Sensitivity in Cancer
glioblastoma
HepG2
Huh7
human epidermal growth factor receptor 3 (HER3)
hybrid steroidal alkylating agents
in vivo imaging
invasion
isatin sulfonamides
K562
MAPK
mesenchymal-amoeboid transition
microtubule acetylation
migration
molecular docking
n/a
nanoparticles
nanosystems
NF-κB
oncogene
ovarian cancer
phortress
photon upconversion
PLGA
poly (ADP-ribose) polymerase inhibitors
prodrug
RNA interference
siRNA
synthetic lethality
triple-negative breast cancer
triplet-triplet annihilation
ISBN 3-0365-5222-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Novel Anti-cancer Agents and Cellular Targets and Their Mechanism
Record Nr. UNINA-9910619465503321
Allison Simon J  
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Radiopharmaceuticals for PET Imaging - Issue A
Radiopharmaceuticals for PET Imaging - Issue A
Autore Roivainen Anne
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (212 p.)
Soggetto topico Medicine
Soggetto non controllato (S)-(−)-[18F]fluspidine
[11C]carfentanil
[18F]AlF
[18F]FACH
18F-fluorodeoxyglucose
18F-labeled analog of FACH
affibody molecule
AlF-radiolabelling
animal model
bioconjugation
bioorthogonal chemistry
blood-brain barrier (BBB)
carfentanil
clinical outcomes
EGFR
FACH
fentanyl
fluorine-18
gallium-68
image-based internal dosimetry
imaging-based biomarker
indium-11
infection
inflammation
inverse electron-demand Diels-Alder ligation
isotopic exchange
kinetic analysis
linker
MCT1/MCT4 lactate transporter inhibitor
metabolic stability
molecular imaging
monocarboxylate transporters (MCTs)
multiple myeloma
naloxone
nanobody
NODAGA
NOTA
OLINDA
opioid
orthotopic xenograft of glioblastoma in mouse
osteomyelitis
overdose
peptides
PET
PET imaging
PET radiotracers
pharmacokinetics
PODS
positron emission tomography
positron emission tomography (PET) imaging
positron emission tomography (PET), defluorination
positron emission tomography/computed tomography
preclinical development
preclinical radiopharmaceutical dosimetry
proteolysis
radiation safety
radiochemistry
radiopharmaceuticals
receptor occupancy
Siglec-9
sigma-1 receptor availability
silicon-based fluoride acceptor
single-domain antibody
small animal Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI)
SPECT
Staphylococcus aureus
sub-millimetre resolution
SV2A protein
synaptic loss
tetrazine
tetrazine ligation
thiol-reactive
tumor imaging
VAP-1
vascular adhesion protein
vulnerable plaque
α-CCA
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557437003321
Roivainen Anne  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui